Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Related Citations for PubMed (Select 21304000)

1.

Markers of pancreatic cancer: working toward early detection.

Goggins M.

Clin Cancer Res. 2011 Feb 15;17(4):635-7. doi: 10.1158/1078-0432.CCR-10-3074. Epub 2011 Feb 8.

2.

Molecular markers in pancreatic cancer diagnosis.

Herreros-Villanueva M, Gironella M, Castells A, Bujanda L.

Clin Chim Acta. 2013 Mar 15;418:22-9. doi: 10.1016/j.cca.2012.12.025. Epub 2013 Jan 8. Review.

PMID:
23305796
3.

Identifying molecular markers for the early detection of pancreatic neoplasia.

Goggins M.

Semin Oncol. 2007 Aug;34(4):303-10. Review. Erratum in: Semin Oncol. 2012 Dec;39(6):716.

4.

Pancreatic cancer and cancer screening programs: from nihilism to hope.

Pezzilli R, Corinaldesi R, Morselli-Labate AM.

JOP. 2010 Nov 9;11(6):654-5. No abstract available.

5.
6.

Identification of early-stage pancreatic cancer biomarkers.

[No authors listed]

Expert Rev Mol Diagn. 2008 Nov;8(6):675. doi: 10.1586/14737159.8.6.675. No abstract available.

PMID:
18999919
7.

Development of serum parameters panels for the early detection of pancreatic cancer.

Zhang P, Zou M, Wen X, Gu F, Li J, Liu G, Dong J, Deng X, Gao J, Li X, Jia X, Dong Z, Chen L, Wang Y, Tian Y.

Int J Cancer. 2014 Jun 1;134(11):2646-55. doi: 10.1002/ijc.28584. Epub 2013 Nov 19.

PMID:
24615168
9.
10.

Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.

Novotný I, Dítĕ P, Dastych M, Záková A, Trna J, Novotná H, Nechutová H.

Hepatogastroenterology. 2008 Jul-Aug;55(85):1475-7.

PMID:
18795715
11.

Prognostic markers in pancreatic ductal adenocarcinomas.

Hezel AF, Bardeesy N.

Cancer Biol Ther. 2008 Sep;7(9):1360-1. Epub 2008 Sep 6. No abstract available.

12.

[Recent advances in diagnosis of pancreatic cancer].

Yamaguchi K, Ogawa Y, Yokohata K, Konomi H, Nakamura M, Nagata S, Tanaka M.

Gan To Kagaku Ryoho. 2005 May;32(5):612-6. Japanese.

PMID:
15918559
13.

Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts.

Kanda M, Knight S, Topazian M, Syngal S, Farrell J, Lee J, Kamel I, Lennon AM, Borges M, Young A, Fujiwara S, Seike J, Eshleman J, Hruban RH, Canto MI, Goggins M.

Gut. 2013 Jul;62(7):1024-33. doi: 10.1136/gutjnl-2012-302823. Epub 2012 Aug 2.

14.

Changing the way we do business: recommendations to accelerate biomarker development in pancreatic cancer.

Tempero MA, Klimstra D, Berlin J, Hollingsworth T, Kim P, Merchant N, Moore M, Pleskow D, Wang-Gillam A, Lowy AM.

Clin Cancer Res. 2013 Feb 1;19(3):538-40. doi: 10.1158/1078-0432.CCR-12-2745. Epub 2013 Jan 23. Review.

15.

Variation in precursor lesions of pancreatic cancer among high-risk groups.

Potjer TP, Schot I, Langer P, Heverhagen JT, Wasser MN, Slater EP, Klöppel G, Morreau HM, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bargello M, Gress TM, Vasen HF, Bartsch DK; Leiden Familial Pancreatic Cancer Group; FaPaCa registry.

Clin Cancer Res. 2013 Jan 15;19(2):442-9. doi: 10.1158/1078-0432.CCR-12-2730. Epub 2012 Nov 21.

16.

Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive.

Fong ZV, Winter JM.

Cancer J. 2012 Nov-Dec;18(6):530-8. doi: 10.1097/PPO.0b013e31827654ea. Review.

PMID:
23187839
17.

Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma.

Takayama R, Nakagawa H, Sawaki A, Mizuno N, Kawai H, Tajika M, Yatabe Y, Matsuo K, Uehara R, Ono K, Nakamura Y, Yamao K.

J Gastroenterol. 2010;45(1):52-9. doi: 10.1007/s00535-009-0114-y. Epub 2009 Sep 30.

PMID:
19789838
18.

The actual management of early pancreatic cancer.

Iglesias García J, Lariño-Noia J, Domínguez-Muñoz JE.

Minerva Gastroenterol Dietol. 2012 Dec;58(4):321-30. Review.

PMID:
23207609
19.

Pancreatic ductal adenocarcinoma screening: new perspectives.

Pezzilli R, Fabbri D, Imbrogno A.

World J Gastroenterol. 2012 Sep 28;18(36):4973-7. doi: 10.3748/wjg.v18.i36.4973.

20.

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

Kobayashi T, Nishiumi S, Ikeda A, Yoshie T, Sakai A, Matsubara A, Izumi Y, Tsumura H, Tsuda M, Nishisaki H, Hayashi N, Kawano S, Fujiwara Y, Minami H, Takenawa T, Azuma T, Yoshida M.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):571-9. doi: 10.1158/1055-9965.EPI-12-1033. Epub 2013 Mar 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk